Avita Medical (ASX:AVH) appointed Chairman Cary Vance as interim chief executive, effective immediately, succeeding Jim Corbett, according to a Friday filing with the Australian bourse.
The board will engage an executive search firm to identify a permanent CEO from internal and external candidates, the filing said.
In the same filing, the company said it anticipates preliminary revenue of around AU$17 million for the third quarter ended Sept. 30.
The company's shares plummeted 20% in recent Friday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.